New COVID-19 pill cut hospital, death risk by 90%
![<i></i><br/>](https://abc17news.b-cdn.net/abc17news.com/2021/06/kmiz-biz-and-tech.png)
By MATTHEW PERRONE
AP Health Writer
WASHINGTON (AP) — Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections. The company announced Friday it will soon ask the U.S. Food and Drug Administration and international regulators to authorize its pill, which is taken twice a day for five days. A similar pill from competitor Merck is currently under FDA review and was cleared Thursday by U.K. regulators. Drugmakers around the world have been racing to develop an easy-to-use pill to blunt the effects of COVID-19. All therapies now authorized in the U.S. require an IV or injection.